Health News Releases

  • Today May 19
April 06, 2017 10:45
Boehringer Ingelheim: A New World Leader in Animal Health
Three months after acquiring animal health leader Merial in a strategic transaction with Sanofi, Boehringer Ingelheim revealed its ambition to compete for industry leadership worldwide in animal healt
April 04, 2017 13:40
Patient Safety Movement Foundation Announces 3rd Annual Patient Safety Innovation Awards
The Patient Safety Movement Foundation (PSMF) announces the 3rd Annual Patient Safety Innovation Awards will open on April 3, 2017 at 12:00 PM PDT. The competition encourages entrepreneurs and patient
April 04, 2017 09:35
Ferring Appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer
Ferring Pharmaceuticals announced today that Dominic Moorhead has been appointed as Executive Vice President and Chief Financial Officer, effective 1st July 2017. Moorhead succeeds Peter Wilden, wh
March 31, 2017 14:00
IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO® Assay
IncellDx, Inc. announces the release of their CE marked OncoTect iO® Lung Kit today, March 30, 2017, entering the immunotherapeutic diagnostic market in Europe and countries that accept the CE- mark a
March 31, 2017 13:00
Takeda Announces Ricardo Marek as New President of Emerging Markets Business Unit
Takeda Pharmaceuticals Company Limited (“Takeda”), announced today that Ricardo Marek has been appointed as the President of the Emerging Markets Business Unit (EM BU), based in Singapore, effective A
March 30, 2017 09:25
Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in Children and Adolescents Living in Dengue-Endemic Areas; Interim Phase 2 Analysis Published in The Lancet Infectious Diseases
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that data from a 6-month interim analysis* of the ongoing DEN-204 trial of its live-attenuated tetravalent dengue vaccine
March 29, 2017 13:50
Heliae Announces First Use of Branded TruAzta Natural Astaxanthin
Heliae, in collaboration with Madre Labs Inc., today announced California GOLD Nutrition Astaxanthin supplement caps branded with a TruAzta™ logo are now available on iHerb.com. This Smart News Rel
March 27, 2017 09:35
China's Healthcare Market to See Surge of Investment and Opportunities in Next 15 Years
Last October, the Chinese government approved a blueprint called “Healthy China 2030”, pledging to build a healthy China in the next 15 years. By 2030, the size of the healthcare market is expected to
March 21, 2017 14:00
Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® and Connectivity Hub with Noninvasive Blood Pressure
Masimo (NASDAQ: MASI) announced today the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter® and connectivity hub. Rad-97 offers Measure-through Motion and
March 20, 2017 17:35
Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation
Important new data from the RE-CIRCUIT® study show a better safety profile for Pradaxa® (dabigatran etexilate) compared to warfarin in atrial fibrillation (AF) patients undergoing catheter ablation. A
March 20, 2017 09:25
First dedicated outcome trials of empagliflozin in chronic heart failure initiated
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the EMPEROR HF clinical trial programme was initiated. EMPEROR HF comprises two Phase III outcome studies that will inve
March 17, 2017 13:55
Ferring Pharmaceuticals: Waking up to Go to the Toilet is the Number One Cause of a Poor Night’s Sleep, Say Experts on World Sleep Day
On World Sleep Day sleep experts encourage people to understand the value of healthy and solid sleep. In particular, if they need to go to the toilet more than once in the night they have nocturia, a
March 16, 2017 13:55
Bioventus to Invest in New Clinical Research for EXOGEN®
Bioventus, a global leader in orthobiologics, today announced it will commission an innovative series of real-world evidence, direct-to-patient studies to further validate the ability of its EXOGEN Ul
March 15, 2017 14:00
First Fibroblast Injection Performed in SpinalCyte’s Landmark Trial for Spinal Disc Regeneration
SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on the regrowth of the spinal disc nucleus using human dermal fibroblasts, announced the first injection of fibroblasts for
March 06, 2017 11:25
New Study by Morinaga Milk, Using Cutting Edge Technology, Confirms Age-Related Changes in Human Gut Microbiota
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading dairy product company in Japan, today announced the results of a new study that show how gut microbiota composition in a healthy human populati
March 06, 2017 09:35
Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy
Celgene Corporation (NASDAQ:CELG) today announced that results from its phase 4 UNVEIL trial evaluating OTEZLA® (apremilast), the Company‘s oral, selective inhibitor of phosphodiesterase 4 (PDE4), in
March 06, 2017 09:20
Celgene to Present New Data from Clinical Trials on Oral OTEZLA® (apremilast) at American Academy of Dermatology Congress
Celgene Corporation (NASDAQ:CELG) today announced that findings from ongoing clinical trials of OTEZLA® (apremilast), the Company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), conducted i
March 03, 2017 09:40
Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
Boehringer Ingelheim announced today a new collaboration with Vanderbilt University, Nashville, Tennessee. The multi-year program complements an already existing collaboration by focusing on the resea
March 02, 2017 16:55
Octapharma Group Publishes 2016 Annual Results Reporting Revenue of €1.6 Billion and Operating Income of €383 Million
The Octapharma Group can report a record-breaking result with sales of €1.6 billion, which represents an increase of €87 million or 5.8% compared with 2015. Octapharma achieved sales growth of 18.8
February 28, 2017 18:55
New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery
Masimo (NASDAQ: MASI) announced today the findings of a recent study conducted on low-risk patients undergoing colorectal surgery, in which researchers assessed the utility of noninvasive and continuo
February 27, 2017 09:45
REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) as monotherapy for
February 17, 2017 14:00
World’s First Medically-Accurate Health Monitoring System Integrated in a Smartphone Now Readied For FDA Approval By Leman Micro Devices
Leman Micro Devices (LMD), the developer of accredited consumer healthcare products that is backed by major players within the mobile device industry, has announced that its Health Sensor & App - the
February 17, 2017 10:35
US FDA Expands Approval of Tiotropium Respimat® for Maintenance Treatment of Asthma in Children
Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved tiotropium Respimat® (marketed as SPIRIVA® Respimat®) for the long-term, once-daily maintenance treatment
February 17, 2017 09:55
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) for $24.00 per share in cash. “W
February 16, 2017 14:00
Masimo Announces CE Marking of Respiration Rate Measurement on MightySat™ Rx
Masimo (NASDAQ: MASI) announced today the CE marking of the measurement of respiration rate from the pleth (RRpTM) on the MightySat™ Rx fingertip pulse oximeter. MightySat Rx is a noninvasive device t
25 per page50 per page75 per page100 per page